Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone
- PMID: 4336233
- PMCID: PMC1647987
- DOI: 10.1136/adc.47.251.62
Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone
Abstract
Measurement of plasma 17-hydroxyprogesterone by a simple competitive protein-binding assay has proved of value in the diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Children with untreated adrenal hyperplasia had high resting levels from as early as the 6th day of life, and children treated with suppressive doses of cortisone showed a rise after adrenal stimulation with tetracosactrin. The method also promises to enhance the ease and precision with which the condition can be managed.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical